MISONIX, Inc. (NASDAQ:MSON) management will conduct a conference call for 3rd September 2020 at 4:30 PM Eastern Time to discuss financial results and companys performance for 4Q20.
The conference call will also be available live on the website edge.media-server.com/mmc/p/74g4drra
To participate in the conference call, local and international callers can dial 800-437-2398 Toll Free, (United States) or 323-289-6576 Toll Number, with passcode : 8353775
Earnings Expectation
MISONIX, Inc. is reporting fourth quarter financial results on Thursday 3rd September 2020, after market close.
According to analysts surveyed by Thomson Reuters, MSON is expected to report 4Q20 loss of $ 0.48 per share from revenue of $ 9.51 million.
For the full year, analysts anticipate top line of $ 58.30 million, while looking forward to loss of $ 1.16 per share bottom line.
The Company Outlook
Revenue for 4Q20 are expected in a range of $ 13.50 million ~ $ 13.50 million
Full Year 2020 topline are forecasted in a range of$ 70.70 million ~ $ 70.70 million
Click Here For More Historical Outlooks Of MISONIX, Inc.
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications.
